Guizhou Yibai Pharmaceutical Co Ltd (600594) — Cash Flow Reinvestment Rate
Guizhou Yibai Pharmaceutical Co Ltd (600594) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥7.08 Million (capex CN¥7.08 Million ) from operating cash flow of CN¥33.28 Million. Check Guizhou Yibai Pharmaceutical Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guizhou Yibai Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for Guizhou Yibai Pharmaceutical Co Ltd across 23 annual periods. Explore Guizhou Yibai Pharmaceutical Co Ltd (600594) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)
Year-by-year capital reinvestment analysis for Guizhou Yibai Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Guizhou Yibai Pharmaceutical Co Ltd (600594) total market value.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.14x | CN¥35.08 Million | CN¥256.71 Million | CN¥34.99 Million | ▼ -89.8% |
| 2024 | 1.34x | CN¥116.31 Million | CN¥86.87 Million | CN¥96.32 Million | ▲ +286.6% |
| 2023 | 0.35x | CN¥130.78 Million | CN¥377.61 Million | CN¥130.38 Million | ▼ -65.1% |
| 2022 | 0.99x | CN¥342.92 Million | CN¥345.30 Million | CN¥322.92 Million | ▲ +69.2% |
| 2021 | 0.59x | CN¥548.48 Million | CN¥934.21 Million | CN¥447.78 Million | ▼ -56.5% |
| 2020 | 1.35x | CN¥494.68 Million | CN¥366.66 Million | CN¥395.74 Million | ▲ +142.1% |
| 2019 | 0.56x | CN¥202.17 Million | CN¥362.71 Million | CN¥201.28 Million | ▼ -62.9% |
| 2018 | 1.50x | CN¥322.01 Million | CN¥214.30 Million | CN¥321.33 Million | ▲ +124.1% |
| 2017 | 0.67x | CN¥457.21 Million | CN¥681.78 Million | CN¥402.80 Million | ▼ -31.6% |
| 2016 | 0.98x | CN¥373.22 Million | CN¥380.62 Million | CN¥332.53 Million | ▲ +95.3% |
| 2015 | 0.50x | CN¥288.02 Million | CN¥573.68 Million | CN¥288.02 Million | ▲ +33.3% |
| 2014 | 0.38x | CN¥203.94 Million | CN¥541.58 Million | CN¥203.94 Million | ▼ -20.5% |
| 2013 | 0.47x | CN¥273.48 Million | CN¥577.24 Million | CN¥273.48 Million | ▼ -34.9% |
| 2012 | 0.73x | CN¥209.64 Million | CN¥288.01 Million | CN¥209.64 Million | ▲ +42.1% |
| 2011 | 0.51x | CN¥142.34 Million | CN¥277.83 Million | CN¥142.34 Million | ▲ +19.3% |
| 2010 | 0.43x | CN¥49.66 Million | CN¥115.66 Million | CN¥49.66 Million | ▼ -0.1% |
| 2009 | 0.43x | CN¥44.62 Million | CN¥103.88 Million | CN¥44.62 Million | ▲ +29.3% |
| 2008 | 0.33x | CN¥62.86 Million | CN¥189.26 Million | CN¥62.86 Million | ▼ -89.8% |
| 2007 | 3.26x | CN¥38.97 Million | CN¥11.94 Million | CN¥38.97 Million | ▲ +1738.0% |
| 2006 | 0.18x | CN¥17.00 Million | CN¥95.77 Million | CN¥17.00 Million | ▼ -96.2% |
| 2005 | 4.66x | CN¥80.99 Million | CN¥17.38 Million | CN¥80.99 Million | ▲ +153.2% |
| 2003 | 1.84x | CN¥169.47 Million | CN¥92.10 Million | CN¥169.47 Million | ▲ +501.0% |
| 2002 | 0.31x | CN¥22.49 Million | CN¥73.46 Million | CN¥22.49 Million | — |